Loeb S, Carter HB, Catalona WJ, Moul JW, and Schroder FH.
“Baseline Prostate-Specific Antigen Testing at a Young Age.”
European Urology January 2012; 61: 1-7. PMID: 21862205.
Link: http://www.ncbi.nlm.nih.gov/pubmed/21862205
This study reviews the published literature showing that baseline PSA measurements at a young age are significant predictors of later prostate cancer diagnosis and disease-specific outcomes. Baseline PSA testing should be offered to young men for risk stratification and to guide screening protocols.